Todd Davis
About Todd Davis
Todd Davis: Chief Executive Officer
Todd Davis serves as the Chief Executive Officer, leveraging over 30 years of operational and investment experience. He has been a pivotal member of the company's Board of Directors since 2007. His extensive background in healthcare financing and leadership has significantly influenced the company's strategic direction.
Todd Davis's Education and Expertise
Todd Davis holds a Bachelor of Science (BS) degree from the U.S. Naval Academy and a Master of Business Administration (MBA) from Harvard Business School. His educational background complements his comprehensive experience in healthcare investment and leadership roles, further enhancing his capability to drive business growth and innovation.
Background and Career of Todd Davis
Todd Davis began his professional journey in sales at Abbott Laboratories. He subsequently held leadership roles at Elan Pharmaceuticals, specializing in corporate development and general management. He was a partner at Apax Partners, responsible for biopharmaceutical growth equity investments. Additionally, he co-founded HealthCare Royalty Partners, growing the firm to approximately $4 billion in capital commitments during his tenure.
Achievements of Todd Davis in Healthcare Financing
Throughout his career, Todd Davis has been involved in more than $3 billion in healthcare financings. His investment expertise has been instrumental in advancing the growth and development of numerous healthcare enterprises. His strategic acumen continues to make a meaningful impact on the industry.
Todd Davis's Board Memberships
Todd Davis currently serves on the boards of Palvella Therapeutics Inc. and ViroCell Biologics, both of which are privately held companies. He is also a former board member of the Harvard Business School Healthcare Alumni Association, further showcasing his commitment to advancing healthcare and life sciences.